Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ImClone, Bristol-Myers Squibb Sign Agreement With Merck
ImClone and Bristol-Myers Squibb have signed an agreement with German pharma major Merck for the co-development and co-commercialization of Erbitux (cetuximab) in Japan. Under the terms of the
ImClone and Bristol-Myers Squibb have signed an agreement with German pharma major Merck for the co-development and co-commercialization of Erbitux (cetuximab) in Japan. Under the terms of the
Approximately 40 sites will participate in each of these two studies, which are being conducted by Wyeth. Each trial is expected to enroll approximately 120 patients who are
Biopure expects to move on several fronts, emphasizing clinical development in Europe. The company has also identified the next step in its ischemia clinical program and has proposed
The Type 1 Diabetes Genetics Consortium (T1DGC) will attempt to identify genes that influence an individual’s risk for developing type 1 diabetes. Principal Investigator Stephen Rich, from the
In consideration for the selective androgen receptor modulator (SARM) program license, Pharmacopeia will apply a portion of its medicinal chemistry resources to an unrelated Bristol-Myers Squibb discovery program
A statistically significant reduction of urinary 5-hydroxyindoleacetic acid, a metabolite of serotonin and biomarker for serotonin production, was observed in subjects who received the highest dose tested, 2,000mg
Corgenix is part of a collaborative group that has developed and patented new recombinant proteins for Lassa virus. The clinical test kits were developed under a $3.8 million
The re-analysis demonstrates that vaginal progesterone is associated with a significantly lower rate of miscarriage than IM progesterone. The data was presented by Dr Paul Zarutskie, Zarutskie Fertility
Additionally, Dynamic has repaid Laurus Master Fund, approximately $5.9 million in full satisfaction of all obligations to Laurus. Mandeep Taneja, president and CEO, said: “It was a pleasure
A patent foramen ovale (PFO) is a common heart defect that may be a potential risk factor for migraine headaches in some patients. The PFO allows venous blood,